Board of Directors
/
Helge Lund
Disease areas
Science & technology
Partnering & innovation
Sustainable business
Careers
About us
Our products
Investors
News & media
Patient help
Contact us
Chair of the board of BP p.l.c.
Operating advisor to Clayton Dubilier & Rice.
Chair of the board of Inkerman Holding AS.
Member of the boards of P/F Tjaldur and Belron SA.
Member of the Board of Trustees of the International Crisis Group.
Chief executive of BG Group plc., 2015-2016.
President and CEO of Equinor ASA, 2004-2014.
President & CEO of Aker Kvaerner ASA, 2002-2004.
Considered independent under the Danish Recommendations on Corporate Governance.
Member of the Board of Directors since 2017 and Chair since 2018. Most recently elected in 2022 for a term of one year.
Member of the Nomination Committee since March 2017 and Chair of the committee since March 2018.
Member of the Board of Directors, 2014-2015.
Global corporate leadership
Healthcare and pharma industry
Finance & accounting
Business development, M&A and external innovation sourcing
Human capital management
Environmental, social and governance (ESG)
1991: MBA, INSEAD, France.
1987: MA in Economics, Norwegian School of Economics & Business Administration (NHH), Norway.
Norwegian, born 1962. Male.